Terms: = Chronic Myelogenous Leukemia AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Staging
36 results:
1. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage Lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.
Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
[TBL] [Abstract] [Full Text] [Related]
2. [De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion].
Matsunaga T; Naganuma K; Tabayashi T; Kawada T; Sakata N; Takahashi Y; Kimura Y; Anan T; Mitsuhashi T; Kubota Y; Sawada K; Yamashita T; Momose S; Higashi M; Tamaru JI; Kizaki M
Rinsho Ketsueki; 2022; 63(12):1643-1647. PubMed ID: 36653137
[TBL] [Abstract] [Full Text] [Related]
3. [Evolvement of a five-way translocation t(5;9;22;6;17) from a four-way Philadelphia translocation t(5;9;22;6) in a rare case of chronic myeloid leukemia].
Kong S; Gu Y; Qin Y; Wang Z; Feng L; Jiang Q; Lai Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1395-1398. PubMed ID: 33306831
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical Study of SCIN Expression and Dromoter Methylation in Patients with chronic Myeloid leukemia].
Zhang ZH; Lian XY; Li XX; He PF; Lin J; Qian J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):646-651. PubMed ID: 31204912
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical Analysis for 42 Imatinib-resistant Patients with chronic myelogenous leukemia].
Liu X; Gan SL; Ma J; Liu YF; Xie XS; Jiang ZX; Cheng YD; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):377-381. PubMed ID: 28446278
[TBL] [Abstract] [Full Text] [Related]
6. Diagnosing and managing advanced chronic myeloid leukemia.
Deininger MW
Am Soc Clin Oncol Educ Book; 2015; ():e381-8. PubMed ID: 25993200
[TBL] [Abstract] [Full Text] [Related]
7. chronic myeloid leukemia as a secondary malignancy after lymphoma in a child. A case report and review of the literature.
Zahra K; Ben Fredj W; Ben Youssef Y; Zaghouani H; Chebchoub I; Zaier M; Badreddine S; Braham N; Sennana H; Khelif A
Onkologie; 2012; 35(11):690-3. PubMed ID: 23147546
[TBL] [Abstract] [Full Text] [Related]
8. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia.
Aumann K; Lassmann S; Schöpflin A; May AM; Wöhrle FU; Zeiser R; Waller CF; Hauschke D; Werner M; Brummer T
Hum Pathol; 2011 May; 42(5):719-26. PubMed ID: 21292300
[TBL] [Abstract] [Full Text] [Related]
9. Methylation status of DDIT3 gene in chronic myeloid leukemia.
Wang YL; Qian J; Lin J; Yao DM; Qian Z; Zhu ZH; Li JY
J Exp Clin Cancer Res; 2010 May; 29(1):54. PubMed ID: 20492726
[TBL] [Abstract] [Full Text] [Related]
10. Milestones and monitoring in patients with cml treated with imatinib.
Deininger MW
Hematology Am Soc Hematol Educ Program; 2008; ():419-26. PubMed ID: 19074120
[TBL] [Abstract] [Full Text] [Related]
11. chronic myeloid leukemia in 2007.
Sessions J
Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S4-9. PubMed ID: 18056931
[TBL] [Abstract] [Full Text] [Related]
12. staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal.
Cortes JE; Talpaz M; O'Brien S; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Rios MB; Shan J; Kantarjian HM
Cancer; 2006 Mar; 106(6):1306-15. PubMed ID: 16463391
[TBL] [Abstract] [Full Text] [Related]
13. A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Leuk Lymphoma; 2006 Mar; 47(3):381-96. PubMed ID: 16396760
[TBL] [Abstract] [Full Text] [Related]
14. Blast count and cytogenetics correlate and are useful parameters for the evaluation of different phases in chronic myeloid leukemia.
Bacher U; Kern W; Schnittger S; Hiddemann W; Schoch C; Haferlach T
Leuk Lymphoma; 2005 Mar; 46(3):357-66. PubMed ID: 15621825
[TBL] [Abstract] [Full Text] [Related]
15. Putting the rap on Akt.
Thompson JE; Thompson CB
J Clin Oncol; 2004 Oct; 22(20):4217-26. PubMed ID: 15483033
[TBL] [Abstract] [Full Text] [Related]
16. Natural history and staging of chronic myelogenous leukemia.
Cortes J
Hematol Oncol Clin North Am; 2004 Jun; 18(3):569-84, viii. PubMed ID: 15271393
[TBL] [Abstract] [Full Text] [Related]
17. Occurrence of a pulmonary carcinoid following allogeneic stem cell transplantation for chronic myelogenous leukemia: a case report.
Fiebiger W; Kurtaran A; Novotny C; Kainberger F; Dekan G; Raderer M
Ann Hematol; 2003 Jun; 82(6):374-6. PubMed ID: 12719884
[TBL] [Abstract] [Full Text] [Related]
18. Clinical significance of cytogenetic analysis in chronic myeloid leukemia (with report of 155 cases).
Du QF; Liu XL; Song LL; Zhang S; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):905-7. PubMed ID: 12377614
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical manifestations and staging system].
Jinnai I
Nihon Rinsho; 2001 Dec; 59(12):2311-5. PubMed ID: 11766331
[TBL] [Abstract] [Full Text] [Related]
20. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
[TBL] [Abstract] [Full Text] [Related]
[Next]
